Myriad RBM, a Q2 Solutions Company, is a CLIA certified testing laboratory that specializes in quantitative measurement of protein biomarkers. With over 300 biomarkers, Myriad RBM offers innovative biomarker services to support pharmacodynamic, prognostic, and predictive clinical studies. Their expertise lies in multiplexed immunoassay testing, providing comprehensive insights into multiple biological pathways, including the immune system and its interaction with growth and tissue factors.

Myriad RBM's ultrasensitive immunoassays utilize Simoa technology to quantify extremely low levels of low abundant protein analytes. They also offer custom Multi-Analyte Profiles (MAPs), allowing customers to choose preconfigured multiplex protein biomarker panels specific to a therapy area or drug mechanism of action. Furthermore, Myriad RBM provides a whole-blood collection and leukocyte culture system for standardized, pharmacodynamic immune-phenotyping studies.

With a long history of assay development, strict quality control measures, and unmatched expertise, Myriad RBM is a trusted partner for pharmacodynamic protein biomarker testing in clinical trials